{"disease":{"id":"immunodeficiency-virus-type-1-human","name":"immunodeficiency virus type 1 human"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02431247","title":"A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":725,"lead_sponsor_name":"Janssen Sciences Ireland UC","has_results":true},{"nct_id":"NCT05261191","title":"A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"MacroGenics","has_results":true},{"nct_id":"NCT05700734","title":"MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}